Evaluation of serum C-reactive protein and lipid profile in patients with myocardial infarction

Leweza B. Abbass

doi:10.15218/zjms.2018.045

Authors

Leweza B. Abbass Department of Clinical Biochemistry, College of Medicine, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2018.045

Keywords:

Myocardial infarction, C-reactive protein, Lipid profile

Abstract

Background and objective: Myocardial infarction is the irreversible death (necrosis) of heart muscle secondary to prolonged lack of oxygen supply (ischemia), when the blood supply to a part of the heart is interrupted, most commonly due to rupture of a vulnerable plaque. The resulting ischemia or oxygen shortage causes damage and potential death of heart tissue. It is a medical emergency, and the leading cause of death worldwide. In this study, we investigated the association of serum C-reactive protein and serum lipid profile with myocardial infarction.

Methods: A cross-sectional study was carried out from January to May 2016 in College of Medicine, Hawler Medical University. The study involved 108 patients with myocardial infarction (70 men and 38 women) in comparison with 50 healthy individuals as the control group (29 men and 21 women).

Results: The levels of serum C-reactive protein were significantly higher (P <0.05) in patients with myocardial infarction in both genders when compared with the control group. There was no statistically significant difference in serum total cholesterol, serum triglyceride and serum LDL-C in patients with myocardial infarction and control group. Regarding serum high-density lipoprotein (HDL-C), there was a statistically significant difference (P <0.01) in patients with myocardial infarction when compared with the control group.

Conclusion: C-reactive protein may play an important role in providing clinicians and biochemists with valuable information regarding diagnosis and following up the patient with suspected myocardial infarction.

Metrics

Metrics Loading ...

References

Isoaito Y, Sato S, Kitamura A, Okamura T, Komach Y. Serum triglycerides and risk of coronary heart disease among Japanese men and women. AJP 2011; 153(5):490–9.

Paoletti R, Gotto A, Hajjar D. Inflammation in atherosclerosis and implications for therapy. Circ 2004; 109(23):111–20.

Choudhry A, Prabhu K, Kase. Association of high sensitive C-reactive protein, lipid profile parameters in South Indian population. IJSRP 2010; 37(2):35–43.

Iciar M, Cristina S, Amparo S, Francisco J. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes 2014; 5(4):444–70.

Behzad H. C-reactive protein and other markers of inflammation in hemodialysis patients Caspian J Intern Med 2013; 4(1):611–6.

Rodolfo P, Chiara B, Andrea P, Andrea C. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag 2006; 2(2):145–52.

Ilya C, Sudhakar V, Utpal S, Suresh CT. Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise Ann N Y Acad Sci 2016; 1363(1):138–54.

KhanHA, Alhomida AS, Sobki SH. Lipid profile of patients withacute myocardial infarction and its correlation with systemic inflammation. Biomark Insights 2013; 8:1–7.

Mehta L, Petters M. Oxidized LDL-C: A critical factor in atherogenesis. Cardiovasc Res 2005; 68(3):353–4.

Calabro P, Goliaand TT. Role of C-reactive protein in acute dial infarction and stroke: possible therapeutic approaches. Curr Pharm Biotechnol 2012; 13(1):4–16.

Chaudhur J, Mridula K, Umamahesh M, Swathi A, Balaraju B. High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iran J Child Neurol 2013; 12(3):92–100.

Shalia K, Savant S, Haldankar V, Nandu T, Pawar P. Study of C-reactive protein and myocardial infarction in the Indian population. Indian J ClinBiochem 2012;27(1):74–82.

Shrivastava A, Singh H, Raizada A, Singh S. Serial measurement of lipid profile and inflammatory markers in patients with acute myocardial infarction. EXCLI J 2015; 14:510–7.

Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K. Oxidized LDL–induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arteriosclerosis, Arterioscler Thromb Vasc Biol 2000; 20(8):1953–60.

Li D, Mehta JL. Antisense to endothelial ox-LDL receptor LOX-1 inhibits ox-LDL-mediated upregulation of MCP-1 expression and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000; 101:2889–96.

Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J BiolChem 2000; 28(275):12633–8.

Elena G, Klaus L. Immune and Inflammatory Mechanisms of Atherosclerosis. Annu Rev Immunol 2009; 27:165–97.

Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 2000; 20:1116–22.